Atlas Trials

Presidio Pharmaceuticals, Inc.

7 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Presidio Pharmaceuticals, Inc.

RecordFirmDate
Phase 1 Study of Relative Bioavailability of PPI-668 New Tablet Versus Capsule Formulations (NCT02258321)Presidio Pharmaceuticals, Inc.2014-10-01
Phase 1 Study of Relative Bioavailability of PPI-668 Tablet and Capsule Formulations (NCT01979484)Presidio Pharmaceuticals, Inc.2013-10-01
A Phase 1a/1b Study of PPI-383 in Healthy Adults and Hepatitis C Patients (NCT01928147)Presidio Pharmaceuticals, Inc.2013-08-01
Study of PPI-668, BI 207127 and Faldaprevir, With and Without Ribavirin, in the Treatment of Chronic Hepatitis C (NCT01859962)Presidio Pharmaceuticals, Inc.2013-05-01
A Drug Interaction Study of the Effects of PPI-668 on the Pharmacokinetics of Midazolam and Omeprazole (NCT01786382)Presidio Pharmaceuticals, Inc.2013-02-01
A Phase 1 Study of PPI-668 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) Genotype 1 (NCT01448200)Presidio Pharmaceuticals, Inc.2011-10-01
A Phase 1b Study of PPI-461 in Patients With HCV Genotype 1 (NCT01247194)Presidio Pharmaceuticals, Inc.2010-10-01

Track Presidio Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.